NSD2 and prostate cancer: Previous studies have shown that NSD2 inhibition potently enhances antigen processing and presentation via complex epigenetic remodeling of prostate cancer cells and that the IFN-γ signaling pathway increases MHC expression to stimulate antitumor immunity14.